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One envisioned function of homologous recombina-
tion (HR) is to find a template for DNA synthesis from
the resected 30-OH molecules that occur during
double-strand break (DSB) repair at collapsed repli-
cation forks. However, the interplay between DNA
synthesis and HR remains poorly understood in
higher eukaryotic cells. Here, we reveal functions
for the breast cancer proteins BRCA2 and PALB2 at
blocked replication forks and show a role for these
proteins in stimulating polymerase h (Polh) to initiate
DNA synthesis. PALB2, BRCA2, and Polh colocalize
at stalled or collapsed replication forks after hy-
droxyurea treatment. Moreover, PALB2 and BRCA2
interact with Polh and are required to sustain the
recruitment of Polh at blocked replication forks.
PALB2 and BRCA2 stimulate Polh-dependent DNA
synthesis on D loop substrates. We conclude that
PALB2 and BRCA2, in addition to their functions in
D loop formation, play crucial roles in the initiation
of recombination-associated DNA synthesis by
Polh-mediated DNA repair.
INTRODUCTION
Faithful DNA replication is essential to prevent accumulation of
mutations and to maintain genome integrity. Replication forks
are vulnerable to unrepaired DNA damage or secondary struc-
tures, which can lead to fork stalling or collapsing. A stalled repli-
cation fork can be arrested, but still has the ability to restart. In
contrast, a collapsed replication fork leads the generation of
replication-dependent DNA double-strand breaks (DSBs), trig-
gering the recruitment of DSB repair (DSBR) machineries. The
tumor-suppressor proteins PALB2 (partner and localizer ofCBRCA2) and BRCA2 (breast cancer type 2 susceptibility protein)
are essential for active homologous recombination (HR)
repair, the main mechanism for error-free, homology-directed
repair of DNA DSBs in mammalian cells (Xia et al., 2006). The
central activity of HR is performed by RAD51, which uses
resected DNA DSBs to invade a homologous double-strand
DNA to form a displacement loop (D loop). Defects in HR cause
genomic instability and promote accumulation of cancer-
promoting mutations. PALB2 and BRCA2 mutations have been
associated with predisposition to breast and pancreatic cancers
(Roy et al., 2012), and PALB2- or BRCA2-deficient cells are
sensitive to PARP inhibitors (Bryant et al., 2005; Buisson et al.,
2010). Furthermore, PALB2 (FANCN) and BRCA2 (FANCD1)
are mutated in a subgroup of Fanconi anemia (Howlett et al.,
2002; Xia et al., 2007), an inherited genomic instability disorder
caused by mutations in genes that regulate the replication-
dependent removal of interstrand DNA crosslinks (Moldovan
and D’Andrea, 2009).
PALB2 links BRCA1 and BRCA2 to promote efficient DNA
repair by HR (Sy et al., 2009a; Xia et al., 2006; Zhang et al.,
2009a, 2009b). In the absence of PALB2, the recruitment of
BRCA2 and RAD51 to DSBs is defective (Xia et al., 2006,
2007). PALB2 interacts with BRCA1 via its N-terminal coiled-
coil domain (Buisson and Masson, 2012; Sy et al., 2009b; Zhang
et al., 2009a, 2009b) and with BRCA2 via its C-terminal WD40
domain (Xia et al., 2007). The coiled-coil domain is also important
for the self-interaction of PALB2. In the presence of DNA
damage, PALB2 dissociates and interacts with BRCA1 to allow
PALB2 localization and HR activation (Buisson and Masson,
2012). A third domain, named ChAM (chromatin-association
motif), is located at the center of the protein (395–446 amino
acids) and is required for PALB2 chromatin localization (Bleuyard
et al., 2012). Recently, we showed that purified PALB2 binds
D loops preferentially and interacts directly with RAD51 to stim-
ulate strand invasion (Buisson et al., 2010; Dray et al., 2010). At
the same time, Jensen et al. (2010), Liu et al. (2010), and Thor-
slund et al. (2010) reported the purification of full-lengthell Reports 6, 553–564, February 13, 2014 ª2014 The Authors 553
BRCA2 and showed that human BRCA2 promotes RAD51 fila-
ment assembly on single-strand DNA (ssDNA), which stimulates
RAD51-mediated DNA strand exchange.
Following D loop formation by RAD51, the 30 tail end ssDNA
is used as a primer for extension by polymerases. The poly-
merases d, h, y, ε, z, k, and REV1 have all been shown to be
involved in HR, although their exact functions remain unclear.
Currently, only polymerases d, h, and k are known to extend
a D loop structure after RAD51 ssDNA invasion (Li et al.,
2013; McIlwraith et al., 2005; Sebesta et al., 2011, 2013; Snee-
den et al., 2013). Genetic evidence obtained in yeast clearly
showed that polymerase d (Pold) is important for HR and gene
conversion (Holmes and Haber, 1999; Maloisel et al., 2008),
but these results have not yet been confirmed in human cells.
Moreover, it was recently shown that subunit p12 of Pold is
degraded in S phase by the CRL4cdt2 complex after replica-
tive-associated DNA damage (Terai et al., 2013; Zhang et al.,
2013). These results suggest that in human cells, Pold may
not be essential for stalled and collapsed replication forks
repair. However, further investigations will be necessary to
better elucidate the regulation of Pold after DNA damage and
the biological significance of this observation. In DT40 cells,
Polh-deficient cells showed a significant decrease in the
frequency of both immunoglobulin (Ig) gene conversion and
HR-dependent repair of I-SceI-induced DSBs when compared
with wild-type cells (Kawamoto et al., 2005). Interestingly, in
human cells, overexpression of Polh and Polk leads to an
increase in HR frequency (Sebesta et al., 2013), and the
absence of Polh slightly decreases HR (Moldovan et al.,
2010). Deletion of both Polh and Polk leads to a 50% decrease
in HR frequency (Sebesta et al., 2013), suggesting a coopera-
tion mechanism between these polymerases.
We hypothesized that different polymerases could be involved
in recombination-associated DNA synthesis. In this study, we
focused on Polh in order to better define its function in HR.
Polh has been shown to colocalize and interact with RAD51
(Kannouche et al., 2001; McIlwraith et al., 2005), and several
studies have shown that, contrary to Pold and Polk, Polh activity
for D-loop extension does not require the loading of PCNA and
RFC (Li et al., 2013; McIlwraith et al., 2005; Sebesta et al.,
2011, 2013; Sneeden et al., 2013). These results suggest that
Polh activity could be regulated by other factors.
In humans, the deletion of Polh leads to xeroderma pigmen-
tosum variant (XPV), which is associated with an increased risk
of skin cancer induced by UV radiation (Johnson et al., 1999;
Masutani et al., 1999). Polh is a member of the Y-family DNA
polymerases (along with Poli, Polk, and REV1), which
specialize in performing DNA-damage bypass repairs involving
TT-cyclobutane pyrimidine dimer (CPD) (Masutani et al., 1999),
8-oxoguanine (8-oxoG) (Haracska et al., 2000b), or O6-methyl-
guanine (me6G) (Haracska et al., 2000a). These DNA lesions
can cause collapsed replication forks, impeding lesion bypass
by replicative DNA polymerases (Polε and Pold). Although the
biological role of Polh in UV-induced DNA damage repair is
well understood, very little is known about the regulation of
Polh activity during HR repair.
In this study, we show that Polh interacts directly with PALB2
and BRCA2 at DSBs induced by collapsed replication forks. We554 Cell Reports 6, 553–564, February 13, 2014 ª2014 The Authorsshow that PALB2 and BRCA2 are important for (1) Polh locali-
zation to collapsed replication forks and (2) Polh-dependent
DNA synthesis for D-loop extension. Our results establish
PALB2 and BRCA2 as key regulators of the extension step after
strand invasion at replication-dependent DSBs.
RESULTS
PALB2 and BRCA2 Promote the Accumulation of Polh at
Collapsed Replication Forks
To better define the function and regulation of Polh at DSBs,
we focused on the localization and recruitment of Polhwith other
HR proteins in the presence of replication-fork stalling agents
such as hydroxyurea (HU), aphidicolin, and mitomycin C
(MMC). These drugs cause collapsed replication forks after
prolonged exposure (Petermann et al., 2010). First, we
confirmed previously published reports showing that Polh-
deficient cells present a defect in repairing DSBs (de Feraudy
et al., 2007; Kawamoto et al., 2005; Moldovan et al., 2010;
Sebesta et al., 2013). We used XPV cells (Polh-deficient cell
line) complemented or not with εGFP-Polh. After MMC treat-
ment, Polh-deficient XPV cells showed a stronger accumulation
of DSBs compared with Polh-complemented XPV cells 24–48 hr
after release into fresh medium (Figure 1A). As a control, we also
showed that these Polh-complemented XPV cells rescued UV
sensitivity (Figure S1A). Next, we scrutinized the localization of
Polh at blocked replication forks. We confirmed that Polh forms
foci after MMC, HU, and aphidicolin treatment (Figure S1B).
Furthermore, PALB2, BRCA2, RAD51, PCNA, RPA and/or
g-H2AX colocalized with Polh at DSBs induced by collapsed
replication forks in HeLa or Polh-εGFP-complemented XPV cells
(Figures 1A, 1B, S1C, and S1D). We used HU and aphidicolin
rather than MMC because it is very difficult to observe PALB2
and BRCA2 foci after MMC treatment, owing to their smaller
size. As proof that the localization of Polh occurs at collapsed
replication forks, we observed that about 70% of the cells
displayed a colocalization between Polh and the DSB marker
RAD51 (Figure S1E). Nevertheless, the exact percentage of forks
that are broken may be smaller, as RAD51 is also localized to
stalled forks that are not broken (Petermann et al., 2010). In
contrast, g-irradiation-induced Polh foci formation was very
limited, confirming previous observations (Kannouche et al.,
2001), and the few foci we observed did not colocalize with
PALB2, RAD51, or g-H2AX (Figures 1C and S1F), suggesting a
role for Polh in DSBR uniquely at blocked replication forks.
Next, we wondered whether Polh localization at collapsed repli-
cation forks is affected by HR proteins. We used siRNAs against
PALB2 or BRCA2, two key regulators of RAD51 and HR activity,
in Polh-εGFP-complemented XPV cells (Figure S1G). In PALB2
or BRCA2 knockdowns, Polh was still recruited to DSBs; how-
ever, we observed a significant decrease in the intensity of
Polh foci (quantified in Figure 2), suggesting that PALB2 and
BRCA2 are important for Polh accumulation at replication-
dependent DNA DSBs (see also Figure S1H).
These results show that PALB2 and BRCA2 are required for
the accumulation of Polh at DSBs triggered by collapsed replica-
tion forks, and provide evidence that PALB2 and BRCA2 could
be important for Polh activity.
BA
PA
LB
2
2
ACRB
IP
A
D
M
er
ge
 
PA
LB
2
D
A
PI
M
er
ge
 
po
lη
-ε
G
FP
0 12 24 36 48 0 12 24 36 48M
6 μM MMC 3h
XPV+ polη-εGFPXPV+ εGFP
225 kpb
295 kpb
375 kpb
450 kpb
555 kpb
1900 kpb
DSB
genomic
DNA
α-Polη
α-GAPDH
(h of release)
XPV + polη-εGFP
(2 mM HU)
PALB2 DAPIMerge polη-εGFPBRCA2 XPV + polη-εG
FP
IR
 (1
0G
y)
PALB2 Polη-εGFP DAPIH2AX PALB2 + H2AX
A
ph
id
ic
ol
in
 (1
 μ
g/
m
L)
C
Hela (2 mM HU)
XPV + polη-εG
FP
D
Figure 1. Polh, PALB2, and BRCA2 Recruitment at Replication-Dependent DNA Double-Strand Breaks
(A) Pulsed-field gel electrophoresis was used to visualize DSB formation in XPV cells complemented with εGFP or Polh-εGFP, after treatment with 6 mMMMC for
3 hr and release for the times indicated.
(B) Colocalization of PALB2 and BRCA2 or PALB2 and Polh-εGFP at DSBs induced by HU. DNA was counterstained with DAPI.
(C and D) Immunofluorescence staining of the indicated DNA repair proteins at DSBs induced by aphidicolin or IR treatment in XPV cells complemented with
Polh-εGFP. DNA was counterstained with DAPI. The white arrows indicate colocalization of PALB2 and g-H2AX.
See also Figure S1.
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Figure 2. Knockdown of PALB2 or BRCA2
Decreases Polh Foci Formation
(A) Representative example of Polh-εGFP foci
intensity in cells transfected with a control siRNA
or PALB2 siRNA.
(B) Quantification of Polh-εGFP foci intensity
induced by HU treatment in control and PALB2 or
BRCA2 knockdowns. ***p < 0.001. The median is
represented by a black line.Purified PALB2 and BRCA2 Stimulate Polh
A key step in HR is the formation of a D-loop structure, char-
acterized by the invasion of a ssDNA into a homologous duplex
DNA. We purified human BRCA2 (Figure 3A), Polh (Figure 3B),
and PALB2 (Buisson et al., 2010) in order to see whether both
PALB2 and BRCA2 could directly affect the DNA polymeriza-
tion activity of Polh. First, we confirmed the ability of Polh to
promote DNA synthesis on a D-loop substrate (Figure S2A).
A control reaction showed that, at 2 nM Polh, only a few syn-
thesis products were detected below 48 nt, while DNA synthe-
sis was complete for some of the events (60 nt) (Figure 3C, lane
2). Then, when Polh was supplemented with increasing con-
centrations of purified PALB2, a strong stimulation of Polh-
dependent DNA synthesis was observed, leading to intermedi-
ate- and full-length DNA products (lanes 3–6). Since PALB2 is a
major partner of BRCA2, it was important to test whether
BRCA2 could also stimulate Polh. Purified BRCA2 also stimu-
lated Polh, although less efficiently than PALB2. Because it is
technically difficult to purify BRCA2, we also used a functional
BRCA2 chimera protein (termed piccolo BRCA2 or piBRCA2)
to test Polh stimulation with a higher concentration of protein.
We previously showed that piBRCA2 has properties very
similar to those of full-length BRCA2, as it stimulates RAD51
D-loop formation and the accumulation of RAD51 on chromatin
(Buisson et al., 2010). piBRCA2 enhanced Polh activity (Fig-
ure S2B). Time-course experiments revealed that DNA was
synthesized progressively over a 30 min period (Figures S2C
and S2D).
To confirm the specificity of PALB2/BRCA2 stimulation of
Polh, we performed several controls. First, we used E. coli
DNA polymerase I Klenow fragment (30–50 exo) (Figure S3A).
PALB2 or piBRCA2 failed to stimulate Klenow polymerase,
and indeed, its activity was inhibited (Figures 4A and S3B). Sec-
ond, unlike PALB2 and BRCA2, BRCA1 did not enhance Polh
activity (Figure S3C), although BRCA1 is necessary for their
recruitment to DSBs. Third, in E. coli, the single-strand binding
protein, SSB, recruits DNA polymerase V (Polh homolog) to
the primer end of RecA-coated DNA for DNA synthesis (Arad
et al., 2008). Unlike what was observed in bacteria, human556 Cell Reports 6, 553–564, February 13, 2014 ª2014 The AuthorsRPA protein did not activate Polh (Fig-
ure S3D). We then used a BRCA2 homo-
log from Leishmania infantum, which
bears the DNA-binding domain BRC7
and BRC8-like repeats. Like hBRCA2,
LiBRCA2 stimulates LiRAD51 in recombi-
nation assays (Genois et al., 2012).
Importantly, LiBRCA2 failed to stimulatehuman Polh, suggesting that the observed stimulation is
specific for human BRCA2 protein (Figure 4B). In addition,
RAD52 was not able to enhance Polh-mediated DNA synthesis,
suggesting that a DNA annealing activity is not required
(Figure S3E).
To further demonstrate that PALB2 and BRCA2 stimulate
Polh DNA synthesis, we used a D-loop substrate that is more
similar to those found in eukaryotes in vivo. The D-loop DNA
substrate was purified from a RAD51-mediated D-loop assay
(Figure S4A). When this substrate was used, Polh extended
the invaded ssDNA only poorly (Figure 4C, lane 2). However,
the addition of PALB2 (cf. lanes 2 and 3–5), BRCA2 (Figure 4D,
cf. lane 2 with lanes 3 and 4), or piBRCA2 (Figure S4B)
increased Polh-mediated DNA synthesis. We removed RAD51
during the D-loop purification step to be sure that DNA synthe-
sis was not stimulated artificially by increased D-loop formation
due to RAD51 (enhanced by the presence of PALB2/BRCA2).
Polh was activated rapidly in the presence of PALB2 or
piBRCA2 (Figures 4C and S4B), but the extension ceased after
addition of 50–100 nt. Topological constraints severely affect
DNA synthesis (Li et al., 2009). Adding topoisomerase I at a
concentration that transformed supercoiled plasmids into
relaxed plasmids (Figure S4C) did not affect Polh/PALB2 or
Polh/piBRCA2 DNA extension, suggesting that halted DNA
synthesis is not caused by a topological constraint (Figures
S4D and S4E).
Our data can suggest that PALB2 and BRCA2 target Polh at
the 30 terminus for DNA synthesis. We used a primer accessibility
assay to monitor whether PALB2 and BRCA2 bind the 30 end of
the primer within the D-loop structure. In this assay, PALB2 or
piBRCA2 were bound to the D-loop substrate, followed by the
addition of E. coli exonuclease III (Exo III) to excise the primer
terminus in the 30–50 direction. Control reactions showed that
Exo III degraded the 50-labeled primer (Figures S5A and S5B,
lane 2). However, when PALB2 or piBRCA2 was added before
Exo III, a region of 10 nt from the 30 end was protected from
degradation (Figures S5A and S5B). Hence, our results suggest
that PALB2 and BRCA2 bind the 30 end of D-loop substrates to
initiate DNA synthesis by Polh.
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Figure 3. PALB2 and BRCA2 Stimulate D-Loop Extension by Polh
(A and B) SDS-PAGE of purified human BRCA2 (A) or Polh (B) stained by silver stain or Coomassie blue, respectively.
(C and D) 32P-labeled D-loop was incubated with Polh (2 nM) with the indicated amounts of purified PALB2 or BRCA2. DNA synthesis products were analyzed by
denaturing PAGE.
See also Figure S2.Direct Interaction between Polh and PALB2 or BRCA2 Is
Required for Stimulation of DNA Synthesis
As suggested by the colocalization of PALB2 and BRCA2 with
Polh in immunofluorescence studies, we found that Polh
coimmunoprecipitated with endogenous PALB2 or BRCA2 in
XPV-complemented cells (Figures 5A and 5B). We also detected
a complex among endogenous Polh, BRCA2, and PALB2 in
untreated and HU-treated U2OS cells (Figure S5C). Moreover,
the stimulatory effect of PALB2 and BRCA2 on Polh suggested
that these proteins could interact directly. Tomap the interaction
regions between Polh and both PALB2 and BRCA2, we usedCa series of nonoverlapping glutathione S-transferase (GST)
fusion proteins (designated PALB2 P2-T1 to P2-T5, and
BRCA2 B2-T1 to B2-T9; Figures 5C and 5D) to define the regions
of PALB2 and BRCA2 that interact with Polh. GST pull-down
assays revealed that Polh binds the WD40 domain of PALB2
(residues 853–1,186) (Figure 5E) and truncation 4 of BRCA2
(residues 1,338–1,781) containing the BRC3, BRC4, and BRC5
domains (Figure 5F). In addition, we found that both purified
PALB2 and piBRCA2 bind Polh directly (Figure 5G). Since the
purification scheme of these proteins includes a benzonase
treatment, we infer that this interaction is not DNA mediated.ell Reports 6, 553–564, February 13, 2014 ª2014 The Authors 557
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See also Figures S3–S5.Given that piBRCA2 bears the BRC3/4 domain and interacts
directly with Polh, we purified a smaller GST fragment of trun-
cation 4 with only BRC3/4. GST-BRC3/4 still interacted with
Polhwith the same affinity as truncation 4 of BRCA2 (Figure 5H).
We next examined whether the Polh interaction domains
within PALB2 or BRCA2 were important for Polh stimulation.
We purified PALB2Q775X, a mutant of PALB2 with a nonsense
codon just before the WD40 domain (Figures S6A and S6B).
This mutant was found in French-Canadian women with breast
cancer (Foulkes et al., 2007). Since it bears intact DNA-binding
domains, PALB2Q775X binds DNA similarly to full-length PALB2
(Figure S6C). Remarkably, PALB2Q775X completely lost its ability
to enhance Polh DNA synthesis and extend D loop oligo-
nucleotide substrates (Figures 6A and S6D) or purified D loops
(Figure S6E). Similar experiments were also performed with
piBRCA2 and BRCA2. We deleted the BRC3/4 domain from
the piBRCA2 chimera or full-length BRCA2 (Figures S6F–S6J
and S7A–S7C). Unlike piBRCA2 and BRCA2, piBRCA2DBRC3/4
and BRCA2DBRC3/4 failed to enhance Polh DNA synthesis
(Figures 6B–6D, S6I, and S6J), whereas both proteins displayed
similar DNA-binding properties (Figures S6H and S7C). These
results show that the WD40 domain of PALB2 and the BRC3/4
repeat of BRCA2 are crucial for DNA synthesis by Polh.
Next, we tested whether disruption of the Polh interaction
domains inPALB2andBRCA2affectedPolh foci formation invivo
after HU treatment. First, consistent with our previous data, the
interaction between PALB2 and Polh was lost with a C-terminal
truncation mutation containing the WD40 domain (PALB2Q775X;
Figure S7D), while deletion of BRC3/4 in piBRCA2 abrogated
the interaction with Polh (Figure S7E). These siRNA-resistant
constructs, along with wild-type controls, were used to comple-
ment siPALB2 and siBRCA2 cells, respectively. Polh foci forma-558 Cell Reports 6, 553–564, February 13, 2014 ª2014 The Authorstion was severely affected in siPALB2
and siBRCA2 cells transfected with
PALB2Q775X or piBRCA2DBRC3/4 com-
pared with wild-type constructs (Figures
7A–C and S7F). These results show thatthe WD40 domain of PALB2 and the BRC3/4 repeat of BRCA2
are important for Polh foci formation at broken replication forks.
DISCUSSION
Replicative DNA polymerases are often stalled by DNA lesions,
and the replication blockage is released by translesion DNA
synthesis andHR. How these processes are intertwined in higher
eukaryotic cells is still poorly understood. Our data reveal roles
for BRCA2 and PALB2 in coordinating the DNA synthesis step
of HR during the repair of replication forks.
PALB2 and BRCA2: Two Important Players at Blocked
DNA Replication Forks
Our results show that PALB2 and BRCA2 are important for the
proper localization of Polh to DSBs at replication forks and to
enhance its activity for D loop extension. Recent studies have
ascribed a new role to BRCA2/PALB2 tumor suppressors at
broken replication forks. Unlike collapsed replication forks,
which require active HR for repair (Petermann et al., 2010),
RAD51 promotes replication restart independently of HR at
stalled replication forks. A possible model is that, at stalled repli-
cation forks, helicases such as WRN, BLM, and SMARCAL1
facilitate fork regression into a ‘‘chicken-foot’’ structure that is
protected against MRE11 degradation by the BRCA pathway
(Hashimoto et al., 2010; Petermann and Helleday, 2010;
Schlacher et al., 2011, 2012). The BRCA pathway achieves this
function by promoting RAD51 nucleoprotein filament formation
and stabilization at stalled forks (Schlacher et al., 2012). The
double-stranded end of the chicken-foot structure is used by
RAD51 and its mediators to promote strand invasion and
D loop formation. In contrast, prolonged replication blocks,
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Figure 5. PALB2 and BRCA2 Interact Directly with Polh
(A and B) Cell extracts from complemented XPV cells were subjected to immunoprecipitation with antibodies against PALB2 (A) or BRCA2 (B). Immunopre-
cipitated proteins were detected by western blotting with the indicated antibodies.
(C and D) Left: Scheme of the PALB2 (C) or BRCA2 (D) deletion variants fused to GST. Right: SDS-PAGE of the corresponding purified proteins.
(E) GST alone or GST-PALB2 truncations (P2T1–P2T5) were incubated with Polh followed by GST pull-down and detection of Polh by western blotting.
(F) GST alone or GST-BRCA2 truncations (B2T1–B2T9) were incubated with Polh followed by GST pull-down. The beads were washed, and bound proteins were
eluted with Laemmli buffer and revealed by western blotting with the antibodies indicated. The inputs for PALB2 or BRCA2 truncations are shown in (C) and (D).
(G and H) Coimmunoprecipitation of purified PALB2, piBRCA2, B2T4, or BRC3/4 and Polh. Asterisk, degradation products.
See also Figure S5.
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Figure 6. Polh Interaction Domains within PALB2 or piBRCA2 Are Essential for Polh Stimulation
(A–C) 32P-labeled D loop oligonucleotides were first incubated with the indicated concentrations of PALB2 or piBRCA2 with or without the Polh-interacting
domains, followed by the addition of Polh. DNA synthesis products were analyzed by denaturing PAGE.
(D) Quantification of the results shown in (C).
See also Figure S7.causedmainly by a failure to restart, lead to collapsed replication
forks and DSB formation. DSBs are generated by the MUS81-
EME1 complex and then are repaired by RAD51-mediated HR.
In both mechanisms, DNA synthesis is required and Polh action560 Cell Reports 6, 553–564, February 13, 2014 ª2014 The Authorswould benefit from the presence of PALB2 and BRCA2 proteins
after strand invasion.
We show that both PALB2 and BRCA2 bind the 30 end of
the invading strand in the D loop structure. Since PALB2 and
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Figure 7. Deletion of Polh Interaction Domains in PALB2 and piBRCA2 Affects Polh Foci Formation
(A) Quantification of Polh-εGFP foci intensity induced byHU treatment in control and siPALB2 knockdowns complementedwith vector alone, wild-type PALB2, or
PALB2Q775X.
(B) Quantification of Polh-εGFP foci intensity induced by HU treatment in control and siBRCA2 knockdowns complemented with vector alone, wild-type
piBRCA2, or piBRCA2DBRC3/4. ***p < 0.001; ns, not significant between the identified groups. The median is represented by a black line.
(C) Representative images of (A). XPV-complemented cells knocked down for PALB2 and complemented with Flag-PALB2 wild-type or Flag-PALB2Q775X were
assayed for immunofluorescence against Polh (green) or anti-Flag. Anti-Flag immunostaining discriminated transiently transfected cells with Flag-PALB2 wild-
type or Flag-PALB2Q775X. siRNA PALB2-resistant constructs were used.
See also Figure S7.BRCA2 interact with Polh, our data suggest that they target DNA
Polh to the end of the invading strand, in addition to their role in
stimulating RAD51 during strand invasion. We initially planned to
study the function of PALB2 or BRCA2 in the presence of RAD51
in terms of their Polh stimulation activities. However, this is
extremely difficult because one cannot distinguish between the
RAD51 invasion activity promoted by PALB2/BRCA2 and the
Polh elongation activity stimulated by PALB2/BRCA2, given
that elongation is possible only after DNA invasion has occurred.
Hence, we purified D loop structures in order to monitor PALB2/
BRCA2 activity at the elongation step without interference by
RAD51. After D loop formation, RAD51 may be an obstacle to
the initiation of the elongation step in making the 30-OH end inac-
cessible to DNA polymerases. RAD54 is able to eliminate RAD51
at the dsDNA and thereby release the 30-OH (Solinger et al.,C2002). Indeed, in yeast, in the absence of RAD54, Polh and
Pold are unable to extend the D loop structures formed by
RAD51 (Li et al., 2009).
More than One Polymerase Is Required for Effective HR
We have shown that Polh is stimulated by BRCA2 and PALB2
(two regulators of RAD51 at stalled or collapsed replication
forks), which is similar to what is observed in prokaryotic cells.
In E. coli, DNA polymerase V, the prokaryotic homolog of Polh,
catalyzes DNA synthesis on a TLS (Translesion synthesis) sub-
strate in the presence of RecA (the RAD51 homolog in E. coli)
(Pham et al., 2002; Schlacher et al., 2005). Although our data
suggest that Polh-dependent DNA synthesis is enhanced spe-
cifically by BRCA2 and PALB2, we do not exclude the possibility
that other DNA polymerases could be stimulated by BRCA2 andell Reports 6, 553–564, February 13, 2014 ª2014 The Authors 561
PALB2. The human genome encodes at least 13 nuclear DNA
polymerases (Lange et al., 2011). Several polymerases have
been identified as being important for DSBR by HR.
S. cerevisiae Pold affects gene conversion tract length during
mitotic recombination from site-specific DSBs (Maloisel et al.,
2008), and both PCNA-associated DNA Pold and Polε are impor-
tant for gene conversion (Holmes and Haber, 1999). Polymer-
ases z, n, and REV1 have been shown to be involved in DSBR
and their knockdown in human cells causes a significant
decrease of HR (Moldovan et al., 2010; Sharma et al., 2012). In
human cells, Pold, Polh, and Polk are the only polymerases
that are known to be able to extend a D loop structure (Li
et al., 2013; McIlwraith et al., 2005; Sebesta et al., 2011, 2013;
Sneeden et al., 2013). The exact function of all these polymer-
ases in DSBR is still poorly understood, and several polymerases
could replace each other when required. Indeed, a recent report
showed that only the double depletion of Polh and Polk affects
HR significantly (Sebesta et al., 2013). Another possibility is
that these polymerases are involved in different alternative
DSBR pathways. For instance, the DSBR pathway is character-
ized by a second-end capture and double Holliday junction for-
mation, leading to crossover or noncrossover products, whereas
synthesis-dependent strand annealing (SDSA) is characterized
by displacement of the extended D loop by BLM helicase with
annealing with the second extremity of the break, leading to
only noncrossover products (Krejci et al., 2012; Moynahan and
Jasin, 2010). We hypothesize that, depending on the pathway
used, different polymerases could be involved. This is consistent
with recent work showing that expression of an inactive Polh led
to an increase of sister chromatin exchange (Bergoglio et al.,
2013), a phenotype similar to that observed in BLM deficient
cells, suggesting that Polh could be more important in the
SDSA pathway. Furthermore, Pold has been shown to be more
processive than Polh when extending D loop structures (Li
et al., 2009; Sebesta et al., 2013; Sneeden et al., 2013). We hy-
pothesize that Polh will be necessary only for short extension
or for the initiation of D loop extension, and is then substituted
by Pold for the generation of longer track length. In this regard,
it is important to note that Polh is a low-fidelity DNA polymerase.
Thus, enabling extended DNA synthesis by Polh could lead to
enhanced mutagenesis and genomic instability. Finally, we
showed that Polh does not localize to DSBs induced by ionizing
radiation (IR), confirming previous results (Kannouche et al.,
2001). For this reason, we think that Pold or Polk could be the
major player in D loop extension at DSBs not associated with a
replication fork. Further work will be needed to clearly under-
stand the interplay among all of these polymerases, and whether
PALB2 and BRCA2 are also important for their regulation. The
regulation of these polymerases during repair of DNA synthesis
might also be different depending on the species involved, as
PALB2 and BRCA2 are absent in yeast. Hence, binding to
BRCA2 and PALB2 might control the proper use of polymerases
in a temporal and DNA-damage-specific manner in human cells.
Conclusions
Previous studies on BRCA2 and PALB2 clearly established these
proteins as essential regulators of HR through RAD51 regulation.
Our findings show that PALB2 and BRCA2 are important for both562 Cell Reports 6, 553–564, February 13, 2014 ª2014 The AuthorsPolh localization and DNA polymerization activity, leading us to
propose a different mechanistic function for these HR-mediating
proteins. The effect of the PALB2 Q775Xmutant on DNA synthe-
sis was revealing, as this mutation is associated with breast can-
cer (Foulkes et al., 2007). The deleterious effect of this mutation
might be related to its inability to interact with both Polh and
BRCA2. The Q775X mutation might interfere with replication
restart, as in the absence of the WD40 region of PALB2, cells
are sensitive to replication stress by MMC treatment (Tischko-
witz et al., 2007). As a result, PALB2-deficient cells undergo
genome rearrangement and instability as DSBs are not properly
repaired. Altogether, our results suggest that the defects
observed in BRCA2- and PALB2-deficient or mutated cells are
related not only to RAD51-dependent strand invasion but also
to a deficiency in DNA synthesis.
EXPERIMENTAL PROCEDURES
Pulse-Field Gel Electrophoresis
Cells were treated with MMC (6 mM) for 1 hr and released for 0, 12, 24, 36, or
48 hr, or treated with HU (2 mM) and released for 6, 12, 24, and 36 hr. Cells
were harvested after trypsinization and 1% agarose plugs containing
500,000 cells were prepared with a CHEF-disposable plug mold (Bio-Rad).
The cells were lysed by incubation of the plugs in 1 mg/ml proteinase K,
100 mM EDTA, 0.2% sodium deoxycholate, 1% sodium lauryl sarcosine for
48 hr at 37C, and then washed three times for 1 hr with 10 mM Tris-HCl
(pH 8.0), 100 mM EDTA. The plugs were loaded onto a 0.9% agarose gel,
and electrophoresis was performed during 24 hr with a two-block pulse linear
program (block 1: 0.1 s at 30 s, 5.8 V/cm, 14C, angle 120, TBE 0.53, 12 hr;
block 2: 0.1 s at 5 s, 3.6 V/cm, 14C, angle 110, TBE 0.53, 12 hr) in a CHEF-
DR III Pulsed Field Electrophoresis System (BioRad). The DNA was stained
with SYBR Gold (Molecular Probes) and visualized using a Typhoon 9200
scanner (Amersham Pharmacia Biotech).
Protein Purification
PALB2, RAD51, RAD52, RPA, and Polh were purified as previously described
(Baumann et al., 1997; Buisson et al., 2010; Buisson and Masson, 2012;
Henricksen et al., 1994; Masutani et al., 1999; Van Dyck et al., 1998). BRCA1
was obtained fromActiveMotif. Exonuclease III, Topoisomerase I, and Klenow
were purchased from NEB. PiBRCA2 or piBRCA2DBRC3/4 was purified from
baculovirus-infected Sf9 cells. One liter of Sf9 insect cells was infected with
PiBRCA2 or piBRCA2DBRC3/4 baculoviruses for 3 days at 27C. The cell pellet
was resuspended in 40 ml of Flag buffer (50 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 2 mM EDTA, 1 mM dithiothreitol [DTT], 0.25% Triton X-100, and 10%
glycerol) containing protease inhibitors (Roche). The suspension was lysed
using a Dounce homogenizer (10 strokes), sonicated three times for 30 s
(50% output), and then homogenized a second time. Then 15 U/ml of Benzo-
nase and MgCl2 (1 mM) was added for 1 hr at 4
C and insoluble material was
removed by centrifugation (35,000 rpm for 40 min). Then 300 ml of M2 anti-
Flag affinity gel (Invitrogen) was added to the soluble extract for 3 hr at 4C.
The beads were then washed two times with washing buffer (50 mM Tris-HCl
[pH7.5], 250 mM NaCl, 2 mM EDTA, 1 mM DTT, 0.25% Triton X-100, and
10% glycerol) and incubated for 30 min with washing buffer (5 mM ATP and
15 mM MgCl2). After two additional washes with Flag buffer without EDTA
and DTT, proteins were eluted twice in 1 vol of beads with Flag buffer and
500mg/ml of 3X-Flagpeptide for 45minat 4C. The eluted proteinswere pooled
and added in 5 ml of TALON buffer (20 mM NaHPO4 [pH 7.4], 500 mM NaCl,
10% glycerol, 0.02% Triton, 5 mM imidazole). Then 300 ml of TALON resin
(Clontech) was added and incubated for 2 hr at 4C. The TALON resin was
washed three times with TALON buffer. Proteins were eluted with TALON
buffer containing 500 mM imidazole and dialyzed in storage buffer (20 mM
Tris-acetate [pH 8.0], 200mMKOAc, 10%glycerol, 1 mMEDTA, 0.5 mMDTT).
BRCA2 or BRCA2DBRC3/4 was purified from baculovirus-infected Sf9 cells,
and 1 liter of Sf9 insect cells was infected with BRCA2 or BRCA2DBRC3/4
baculoviruses for 3 days at 27C. The cell pellet was resuspended in 40 ml of
Flag buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 2 mM EDTA, 1 mM DTT,
0.02% Triton X-100, and 10% glycerol) containing protease inhibitors (Roche).
The suspension was lysed using a Dounce homogenizer (10 strokes), soni-
cated three times for 30 s (50% output), and then homogenized a second
time. Then 15 U/ml of Benzonase and MgCl2 (1 mM) was added for 1 hr at
4C and insoluble material was removed by centrifugation (35,000 rpm for
40 min). Then 500 ml of GFP-Trap-A beads (Chromotek) was added to the
soluble extract for 3 hr at 4C. Then, the beads were washed two times with
washing buffer (50 mM Tris-HCl [pH 7.5], 250 mM NaCl, 2 mM EDTA, 1 mM
DTT, 0.02% Triton X-100, and 10% glycerol) and incubated for 30 min with
washing buffer, 5 mM ATP, and 15 mM MgCl2. After two additional washes
with Flag buffer, the beads were resuspended in 1.5 ml of Flag buffer contain-
ing 500U of TEV protease (Invitrogen) and incubated for 14 hr. After the elution,
the supernatant was added in 250 ml of M2 anti-Flag affinity gel (Invitrogen) in
10ml of Flag buffer and incubated for 2 hr at 4C. The beadswere thenwashed
two times with washing buffer. After two additional washes with Flag buffer,
proteins were eluted twice in 1 vol of beads with Flag buffer and 500 mg/ml
of 3X-Flag peptide (Invitrogen) for 2 hr at 4C. Each elution was dialyzed sepa-
rately in storage buffer (20 mM Tris-acetate [pH 8.0], 200 mM KOAc, 10%
glycerol, 1 mM EDTA, 0.5 mM DTT).
DNA Synthesis Assays of Synthetic D Loop
Reactions (10 ml) containing 32P-labeled synthetic D loop (500 nM in nucleo-
tides) were incubated with the indicated proteins in buffer containing 10 mM
Tris-HCl (pH 7.5), 60 mM KOAc, 0.7 mM MgCl2, 100 nM deoxyribonucleotide
triphosphate [dNTP], 1mMDTT, and 100 mg/ml BSA for 5min at 37C followed
by the addition of Polh (2 nM) or Klenow (0.25, 0.5, and 2.5 mU). After 20 min
incubation at 37C, reactions were deproteinized with proteinase K (2 mg/ml)
for 20 min at 37C. Formamide was added to a final concentration of 60%
(v/v) and the samples were loaded on a 8% denaturing acrylamide (7 M
urea), 13 TBE gel, run at 75 W, dried, and visualized by autoradiography.
Purification of D Loop Probe
A 32P-labeled 50-mer oligonucleotide substrate (2 mM nucleotides) was incu-
bated for 5 min with 700 nM of RAD51 in 25 mM Tris-HCl (pH 7.5), 60 mM
KOAc, 2.5 mM CaCl2, 300 mM EDTA, 1 mM DTT, 2 mM ATP, and 100 mg/ml
BSA. CsCl-purified pPB4.3 replicative form I DNA (600 mM) was added, and
the reaction was incubated for 15 min and deproteinized with proteinase K
(2 mg/ml) for 20 min at 37C. D loop structure was separated from 50-mer
ssDNA on 0.8% agarose gel (13 TBE) for 2 hr at 65 V and purified by electro-
elution. The purified D loop DNA was dialyzed for 1 hr in water and concen-
trated by speed vac.
DNA Synthesis Assays of Purified D Loop
Reactions (10 ml) containing 32P-labeled purifiedD loop (30 nM)were incubated
with the indicated proteins in buffer containing 10mMTris-HCl (pH 7.5), 60mM
KOAc, 6 mM MgCl2, 100 nM dNTP, 1 mM DTT, and 100 mg/ml BSA for 5 min
at 37C, followed by addition of Polh (2 nM). After 20 min incubation at 37C,
reactions were deproteinized with proteinase K (2 mg/ ml) for 20 min at 37C.
Then 10 mM EDTA and 3 ml of alkaline gel-loading buffer (300 mM NaOH,
6 mM EDTA, 18% Ficoll) were added to the reactions. The samples were
loaded on a 0.8% denaturing agarose gel (50 mM NaOH and 1 mM EDTA),
run at 3.5 V/cm for 2 hr, neutralized in 7% trichloroacetic acid for 30 min, dried
on DE81 filter paper, and visualized by autoradiography.
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